scholarly journals Breast-cancer incidence and mortality rates in different countries in relation to known risk factors and dietary practices

1979 ◽  
Vol 39 (1) ◽  
pp. 1-7 ◽  
Author(s):  
G E Gray ◽  
M C Pike ◽  
B E Henderson
2015 ◽  
Vol 24 (10) ◽  
pp. 1495-1506 ◽  
Author(s):  
Carol E. DeSantis ◽  
Freddie Bray ◽  
Jacques Ferlay ◽  
Joannie Lortet-Tieulent ◽  
Benjamin O. Anderson ◽  
...  

PLoS ONE ◽  
2021 ◽  
Vol 16 (3) ◽  
pp. e0248723
Author(s):  
Shadi Rahimzadeh ◽  
Beata Burczynska ◽  
Alireza Ahmadvand ◽  
Ali Sheidaei ◽  
Sara Khademioureh ◽  
...  

Background In Iran, trends in breast cancer incidence and mortality have generally been monitored at national level. The purpose of this study is to examine province-level disparities in age-standardised breast cancer incidence versus mortality from 2000 to 2010 and their association with socioeconomic status. Methods In this study, data from Iran’s national cancer and death registry systems, and covariates from census and household expenditure surveys were used. We estimated the age-standardised incidence and mortality rates in women aged more than 30 years for all 31 provinces in the consecutive time intervals 2000–2003, 2004–2007 and 2008–2010 using a Bayesian spatial model. Results Mean age-standardised breast cancer incidence across provinces increased over time from 15.0 per 100,000 people (95% credible interval 12.0,18.3) in 2000–2003 to 39.6 (34.5,45.1) in 2008–2010. The mean breast cancer mortality rate declined from 10.9 (8.3,13.8) to 9.9 (7.5,12.5) deaths per 100,000 people in the same period. When grouped by wealth index quintiles, provinces in the highest quintile had higher levels of incidence and mortality. In the wealthiest quintile, reductions in mortality over time were larger than those observed among provinces in the poorest quintile. Relative breast cancer mortality decreased by 16.7% in the highest quintile compared to 10.8% in the lowest quintile. Conclusions Breast cancer incidence has increased over time, with lower incidence in the poorest provinces likely driven by underdiagnoses or late-stage diagnosis. Although the reported mortality rate is still higher in wealthier provinces, the larger decline over time in these provinces indicates a possible future reversal, with the most deprived provinces having higher mortality rates. Ongoing analysis of incidence and mortality at sub-national level is crucial in addressing inequalities in healthcare systems and public health both in Iran and elsewhere.


2019 ◽  
Vol 22 (2) ◽  
pp. 62
Author(s):  
L. F. Pisareva ◽  
N. P. Lyakhova ◽  
D. A. Perinov ◽  
E. V. Panferova ◽  
A. V. Doroshenko ◽  
...  

Author(s):  
Marie Thöle ◽  
Aleksandra Jezierska-Thöle ◽  
Richard Schensar ◽  
Marta Gwiaździńska-Goraj

Introduction: Trends in cancer incidence and mortality are determined by contemporary demographic processes. Breast cancer in women is a particular threat. In Germany, the chances of survival after the diagnosis of cancer are among the highest in Europe. The understanding of the latest trends in breast cancer incidence and mortality in Germany and the presentation of the latest screening options, treatment and prevention methods can be used to improve the control of breast cancer in the future. Aim: The aim of the research was to present trends in cancer incidence and mortality, with particular emphasis on breast cancer in women in Germany and Poland on the background of contemporary demographic changes relating to the process of population ageing in 2006–2016. The clinical diagnostic process, the treatment of breast cancer and potential risk factors and prevention methods were described. Material and methods: In the publication the basic statistical indicators have been applied: absolute numbers, percentages, crude rates, age-standardized rates, and demographic aging index. Results and discussion: The cancer mortality in Poland was much higher than in Germany, which is associated with the low five-year survival rate of cancer patients in Poland. The breast cancer was characterized by the highest dynamics in incidence growth with a persistent mortality level. Conclusions: Over the last two decades, breast cancer outcomes of patients have improved significantly due to highly individualized breast cancer therapies and the development of breast cancer treatment options such as immunotherapy, hormone receptor-based therapy and HER2 status-based therapy. The main risk factors are age, hormonal situation and inherited risk genes.


Sign in / Sign up

Export Citation Format

Share Document